Long-term oncological and surgical outcomes after Video Endoscopic Inguinal Lymphadenectomy (VEIL) in patients with penile cancer
Tobias-Machado, Marcos; Ornellas, Antonio A.; Hidaka, Alexandre K.; Medina, Luis G.; Mattos, Pablo A. L.; Besio, Ruben S.; Abreu, Diego; Castro, Pedro R.; Nishimoto, Ricardo H.; Astigueta, Juan; Dourado, Aurus; Machado, Roberto D.; Magnabosco, Wesley J.; Corona-Montes, Victor; Villoldo, Gustavo M.; Zampolli, Hamilton C.; Taha, Anis; Auad, Pericles R.; Faria, Eliney F.; Arantes, Paulo B. O.; Tavares, Alessandro; Nascimento, Francisco S. M. S.; Brazão Jr., Eder S.; Rocha, Maurício M.; Costa, Walter H.; Panico, Vinicius; Reis, Leonardo O.; Almeida-Carrera, Roberto J.; Silva, Rafael C.; Zequi, Stênio C.; Calixto, José R. R.; Sotelo, Rene.
Int. braz. j. urol
; 49(5): 580-589, Sep.-Oct. 2023. tab, graf
Article
in English
|
LILACS-Express
| ID: biblio-1506417
ABSTRACT
Objective:
To report outcomes from the largest multicenter series of penile cancer patients undergoing video endoscopic inguinal lymphadenectomy (VEIL). Materials andMethods:
Retrospective multicenter analysis. Authors of 21 centers from the Penile Cancer Collaborative Coalition-Latin America (PeC-LA) were included. All centers performed the procedure following the same previously described standardized technique. Inclusion criteria included penile cancer patients with no palpable lymph nodes and intermediate/high-risk disease and those with non-fixed palpable lymph nodes less than 4 cm in diameter. Categorical variables are shown as percentages and frequencies whereas continuous variables as mean and range.Results:
From 2006 to 2020, 210 VEIL procedures were performed in 105 patients. Mean age was 58 (45-68) years old. Mean operative time was 90 minutes (60-120). Mean lymph node yield was 10 nodes (6-16). Complication rate was 15.7%, including severe complications in 1.9% of procedures. Lymphatic and skin complications were noted in 8.6 and 4.8% of patients, respectively. Histopathological analysis revealed lymph node involvement in 26.7% of patients with non-palpable nodes. Inguinal recurrence was observed in 2.8% of patients. 10y- overall survival was 74.2% and 10-y cancer specific survival was 84.8%. CSS for pN0, pN1, pN2 and pN3 were 100%, 82.4%, 72.7% and 9.1%, respectively.Conclusion:
VEIL seems to offer appropriate long term oncological control with minimal morbidity. In the absence of non-invasive stratification measures such as dynamic sentinel node biopsy, VEIL emerged as the alternative for the management of non-bulky lymph nodes in penile cancer.
Responsible library:
BR1.1
Fulltext